Prix FOB
Obtenir le dernier prix0.2 ~ 0.3 / Box ( Negotiable )
|10000 Box Minimum Order
Pays:
China
N ° de modèle:
-
Prix FOB:
0.2 ~ 0.3 / Box ( Negotiable ) Obtenir le dernier prix
Localité:
-
Prix de commande minimale:
0.2 per Box
Commande minimale:
10000 Box
Packaging Detail:
cartons
Heure de livraison:
40days
Capacité de Fournir:
100000 Box per Day
Payment Type:
L/C, T/T
Groupe de produits :
Personne àcontacter Mr. Kevin
No. 35 Huitong Road, Shijiazhuang, China, Shijiazhuang, Hebei
Product Name:Â Dextrose Injection 5% ,Glucose Injection 5%,Dextrose infusion 5%,Glucose infusion 5%
Product Description :A clear, colourless or almost colourless liquid,taste sweet.
Strength:5g/**0ml,*2.5g/**0ml,*5g/**0ml
INN or Generic Name:Hydrous Dextrose
Pharmaceutical Dosage Form:Â Â injection
Port:Any port (depends on
requests)Â Â Â Â Â
 Certificate:GMP
Exporting Region:Areas which GMP is applicable
Therapeutic indications
Intravenous solutions containing Dextrose are indicated for
parenteral replenishment of fluid and minimal carbohydrate
calories as required by the clinical condition of the patient.
Posology and method of administration
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous Dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Drug Interactions
Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Contraindications:
5% Dextrose Injection, USP without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.
Special warning and precautions for use:
Warnings
Excessive administration of potassium-free solutions may result
in significant hypokalemia.
The intravenous administration of these solutions can cause
fluid and/or solute overloading resulting in dilution of serum
electrolyte concentrations, overhydration, congested states or
pulmonary edema.
The risk of dilutional states is inversely proportional to the
electrolyte concentrations of administered parenteral
solutions. The risk of solute overload causing congested states
with peripheral and pulmonary edema is directly proportional to
the electrolyte concentrations of such solutions.
Precautions
Clinical evaluation and periodic laboratory determinations are
necessary to monitor changes in fluid balance, electrolyte
concentrations and acid-base balance during prolonged
parenteral therapy or whenever the condition of the patient
warrants such evaluation.
Solutions containing Dextrose should be used with caution in
patients with known subclinical or overt diabetes mellitus.
Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Carcinogenesis, Mutagenesis, Impairment of
Fertility:
Studies with 5% Dextrose Injection, USP have not been performed
to evaluate carcinogenic potential, mutagenic potential or
effects on fertility.
Interaction with other medicinal products and other forms of Interactions
None known
Pregnancy and lactation
Pregnancy:
Teratogenic effects
Pregnancy Category C. Animal reproduction studies have not been
conducted with Dextrose. It is also not known whether Dextrose
can cause fetal harm when administered to a pregnant woman or can
affect reproduction capacity. Dextrose should be given to a
pregnant woman only if clearly needed.
Nursing Mothers:
Caution should be exercised when 5% Dextrose Injection, USP is
administered to a nursing mother.
Pediatric Use:
The safety and effectiveness in the pediatric population are
based on the similarity of the clinical conditions of the
pediatric and adult populations. In neonates or very small
infants the volume of fluid may affect fluid and electrolyte
balance.
Frequent monitoring of serum glucose concentrations is required
when Dextrose is prescribed to pediatric patients, particularly
neonates and low birth weight infants.
In very low birth weight infants, excessive or rapid
administration of Dextrose injection may result in increased
serum osmolarity and possible intracerebral hemorrhage.
Geriatric Use:
An evaluation of current literature revealed no clinical
experience identifying differences in response between elderly
and younger patients. In general, dose selection for an elderly
patient should be cautious, usually starting at the low end of
the dosing range, reflecting the greater frequency of decreased
hepatic, renal, or cardiac function, and of concomitant disease
or other drug therapy..
Effects on ability to drive and use machine
Not applicable.
Undesirable effects
Reactions which may occur because of the solution or the
technique of administration include febrile response, infection
at the site of injection, venous thrombosis or phlebitis
extending from the site of injection, extravasation and
hypervolemia.
If an adverse reaction does occur, discontinue the infusion,
evaluate the patient, institute appropriate therapeutic
countermeasures and save the remainder of the fluid for
examination if deemed necessary.
Overdose and special antidotes
In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.
| Pays: | China |
| N ° de modèle: | - |
| Prix FOB: | 0.2 ~ 0.3 / Box ( Negotiable ) Obtenir le dernier prix |
| Localité: | - |
| Prix de commande minimale: | 0.2 per Box |
| Commande minimale: | 10000 Box |
| Packaging Detail: | cartons |
| Heure de livraison: | 40days |
| Capacité de Fournir: | 100000 Box per Day |
| Payment Type: | L/C, T/T |
| Groupe de produits : | generic |
